Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Declan G Murphy

Showing results (281-290 of 415) with videos related to

Pageof 42
Sort By:
Nature Reviews. Urology|December 6, 2022
Using PSMA imaging for prognostication in localized and advanced prostate cancerMatthew J Roberts, Tobias Maurer, Marlon Perera, et al.
European Urology|December 20, 2020
Is Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography Imaging Cost-effective in Prostate Cancer: An Analysis Informed by the proPSMA TrialRafael E de Feria Cardet, Michael S Hofman, Tatiana Segard, et al.
European Urology Oncology|August 15, 2019
Poor Outcomes for Patients with Metastatic Castration-resistant Prostate Cancer with Low Prostate-specific Membrane Antigen (PSMA) Expression Deemed Ineligible for <sup>177</sup>Lu-labelled PSMA Radioligand TherapySue Ping Thang, John Violet, Shahneen Sandhu, et al.
European Urology|December 29, 2009
Downsides of robot-assisted laparoscopic radical prostatectomy: limitations and complicationsDeclan G Murphy, Anders Bjartell, Vincenzo Ficarra, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 6, 2026
First Images on a Next-Generation Extended-Field-of-View Digital Bismuth Germanium Oxide Total-Body PET/CTMichael S Hofman, Alicia Corlett, Cameron Pain, et al.
BJU International|April 14, 2026
Guideline of guidelines: lutetium-177 PSMA radioligand therapy in advanced prostate cancerAbdullah Al-Khanaty, David Chen, Jonathan Walbaum, et al.
The Medical Journal of Australia|October 2, 2022
Modern paradigms for prostate cancer detection and managementIsabella Sc Williams, Aoife McVey, Sachin Perera, et al.
Physics and Imaging in Radiation Oncology|March 14, 2022
A statistical, voxelised model of prostate cancer for biologically optimised radiotherapyRobert N Finnegan, Hayley M Reynolds, Martin A Ebert, et al.
The Journal of Urology|October 6, 2020
Is the Toxicity of Salvage Prostatectomy Related to the Primary Prostate Cancer Therapy Received?Luis Ribeiro, Thomas Stonier, Luke Stroman, et al.
Cancers|December 17, 2024
Snap Diagnosis: Developing an Artificial Intelligence Algorithm for Penile Cancer Detection from PhotographsJianliang Liu, Jonathan S O'Brien, Kishor Nandakishor, et al.
Pageof 42

Showing results (281-290 of 415) with videos related to

Sort By:
Pageof 42
Nature Reviews. Urology|December 6, 2022
Using PSMA imaging for prognostication in localized and advanced prostate cancerMatthew J Roberts, Tobias Maurer, Marlon Perera, et al.
European Urology|December 20, 2020
Is Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography Imaging Cost-effective in Prostate Cancer: An Analysis Informed by the proPSMA TrialRafael E de Feria Cardet, Michael S Hofman, Tatiana Segard, et al.
European Urology Oncology|August 15, 2019
Poor Outcomes for Patients with Metastatic Castration-resistant Prostate Cancer with Low Prostate-specific Membrane Antigen (PSMA) Expression Deemed Ineligible for <sup>177</sup>Lu-labelled PSMA Radioligand TherapySue Ping Thang, John Violet, Shahneen Sandhu, et al.
European Urology|December 29, 2009
Downsides of robot-assisted laparoscopic radical prostatectomy: limitations and complicationsDeclan G Murphy, Anders Bjartell, Vincenzo Ficarra, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 6, 2026
First Images on a Next-Generation Extended-Field-of-View Digital Bismuth Germanium Oxide Total-Body PET/CTMichael S Hofman, Alicia Corlett, Cameron Pain, et al.
BJU International|April 14, 2026
Guideline of guidelines: lutetium-177 PSMA radioligand therapy in advanced prostate cancerAbdullah Al-Khanaty, David Chen, Jonathan Walbaum, et al.
The Medical Journal of Australia|October 2, 2022
Modern paradigms for prostate cancer detection and managementIsabella Sc Williams, Aoife McVey, Sachin Perera, et al.
Physics and Imaging in Radiation Oncology|March 14, 2022
A statistical, voxelised model of prostate cancer for biologically optimised radiotherapyRobert N Finnegan, Hayley M Reynolds, Martin A Ebert, et al.
The Journal of Urology|October 6, 2020
Is the Toxicity of Salvage Prostatectomy Related to the Primary Prostate Cancer Therapy Received?Luis Ribeiro, Thomas Stonier, Luke Stroman, et al.
Cancers|December 17, 2024
Snap Diagnosis: Developing an Artificial Intelligence Algorithm for Penile Cancer Detection from PhotographsJianliang Liu, Jonathan S O'Brien, Kishor Nandakishor, et al.
Pageof 42